← Back to Search

68Ga-PSMA for Prostate Cancer

Phase 1 & 2
Waitlist Available
Led By Brian Miles, MD
Research Sponsored by The Methodist Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male aged 21 years or older
Ability to understand and provide written informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Study Summary

This trial is testing a new imaging agent, 68Ga-PSMA 11, to see if it can help guide treatment for men with localized high risk prostate cancer or biochemical recurrence.

Eligible Conditions
  • Prostate Cancer
  • High Risk

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of Patients Which Clinical Management Was Altered
Proportion of Patients With Lymph Node Involvement
Secondary outcome measures
Intensity of Uptake as a Predictor of Clinical Outcome or Aggressiveness
Number of Patients With Suspicious Lesions

Trial Design

1Treatment groups
Experimental Treatment
Group I: 68 Ga PSMAExperimental Treatment1 Intervention
Comparison between the results of 68 Ga-PSMA PET/CT to conventional imaging (bone scan, CT) in men with high risk prostate cancer.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
68Ga-PSMA
2018
Completed Phase 2
~1580

Find a Location

Who is running the clinical trial?

The Methodist Hospital Research InstituteLead Sponsor
270 Previous Clinical Trials
80,168 Total Patients Enrolled
1 Trials studying Prostate Cancer
60 Patients Enrolled for Prostate Cancer
Brian Miles, MD4.021 ReviewsPrincipal Investigator - The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
5Patient Review
Dr. Miles was recommended to us as a specialist who could provide a second opinion on my father's cancer. I'm so glad we went to see him! He was so compassionate and took the time to thoroughly explain everything to us. I would highly recommend him to anyone.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings in this research project?

"The details listed on clinicaltrials.gov indicate that this trial is no longer accepting participants, as the last update was recorded on April 4th 2022. While applications are not being accepted at present, there are over 1300 other studies looking for new volunteers right now."

Answered by AI
~18 spots leftby Mar 2025